Dr. Patrick M. Francke is board certified in Radiation Oncology. He received his Bachelor of Science degree in biology with honors from Western Kentucky University and his medical degree from the University of Louisville School of Medicine in Louisville, Kentucky.
At the end of his residency, he was asked to remain as faculty at the University of Kentucky Department of Radiation Oncology. Dr. Francke actively participated in clinical research and teaching residents and medical students while he was Assistant Professor.
Patrick Francke, MD has published and lectured on numerous topics, including Brachytherapy, Gynecologic Oncology, and Lung Cancer.
Medical School:
University Louisville
Louisville, KY 1990
Internship:
St Vincents
Indianapolis, IN 1991
Residency:
University Ky College Med
Lexington, KY 1994
Boards and Committees
Board Certified in Radiation Oncology
Member of the American Society for Therapeutic Radiology and Oncology, American College of Radiation Oncology (ACRO), American Brachytherapy Society, Florida Medical Association and Broward County Medical Society.
Actively involved in the American Cancer Society.
Affiliations
21st Century Oncology
7850 N University Dr
Tamarac, FL 33321
Practice: (954) 724-8500
21st Century Oncology
266 W Hillsboro Blvd
Deerfield Beach, FL 33441
Practice: (954) 481-8733
Florida Medical Center
5000 West Oakland Parks Boulevard
Fort Lauderdale, FL 33313
Hours
Available By Appointment
Member Since
April 2009
Get Directions From (address and zip code)
Filtered search results allows you to find the information and
location of the doctor you need with out having to review many
listings. Search for specific physicians, procedures, and
locations.
Learn more about this radiation alternative treatment for breast cancer. The Contura device is part of a new class of treatment options designed to reduce the total amount of time spent undergoing radiation therapy, offering a five-day care plan as opposed to the traditional six weeks, returning patients to everyday living as soon as possible.
Recent developments in women's heath have brought about the introduction of the PROLIFT procedure to improve damage done to the female pelvic wall. Used as a method for correcting pelvic prolapse, the procedure is having excellent results for the majority of women choosing PROLIFT over more invasive surgeries.
The Coherex FlatStent PFO Closure System was first used on a human patient in October of 2007 in Frankfurt, Germany. The procedure was done under the direction of Interventional Cardiologist Professor Horst Sievert, M.D. The Ceherex FlatStent was used to close a heart defect commonly referred to as PFO.
The world of medicine is constantly bringing us new, exciting discoveries; and the 2008 FDA approval of the Endeavor Drug-Eluting Stent is yet another amazing advancement. The device has so far proven to be quite effective in helping heart patients with narrowed coronary arteries.